Old Web
English
Sign In
Acemap
>
authorDetail
>
Shoji Takagaki
Shoji Takagaki
Biochemistry
Biology
In vivo
In vitro
Metabolite
4
Papers
37
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.
1998
Japanese Journal of Cancer Research
Yoshinori Naoe
Masamichi Inami
Sanae Matsumoto
Shoji Takagaki
Tomoichi Fujiwara
Sachiko Yamazaki
Ikuo Kawamura
Fusako Nishigaki
Susumu Tsujimoto
Toshitaka Manda
Kyoichi Shimomura
Show All
Source
Cite
Save
Citations (17)
Different Effects of FK317 on Multidrug‐resistant Tumor in vivo and in vitro
1998
Japanese Journal of Cancer Research
Yoshinori Naoe
Masamichi Inami
Shoji Takagaki
Sanae Matsumoto
Ikuo Kawamura
Fusako Nishigaki
Susumu Tsujimoto
Toshitaka Manda
Kyoichi Shimomura
Show All
Source
Cite
Save
Citations (12)
The development of a sensitive and specific enzyme immunoassay for FK480, a novel cholecystokinin type-A receptor antagonist, in human plasma
1998
Journal of Pharmaceutical and Biomedical Analysis
Kazuyoshi Nozaki
Shingo Suzuki
Fumie Maeda
Shoji Takagaki
Akira Suzuki
Takehisa Hata
Show All
Source
Cite
Save
Citations (1)
A new antitumor antibiotic, FK973: its metabolism in the blood and the antitumor effects of its metabolites on experimental models.
1989
Japanese Journal of Pharmacology
Kikuo Masuda
Akira Suzuki
Takaaki Nakamura
Shoji Takagaki
Kosei Noda
Kyoichi Shimomura
Hideyo Noguchi
Fumio Shibayama
Show All
Source
Cite
Save
Citations (7)
1